Menu
Back to Journals » Journal of Inflammation Research » Volume 14
Clinical Trial Report
Efficacy and Safety of First-Generation EGFR-TKIs Combined with Chemotherapy for Treatment-Naïve Advanced Non-Small-Cell Lung Cancer Patients Harboring Sensitive EGFR Mutations: A Single-Center, Open-Label, Single-Arm, Phase II Clinical Trial
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,010 | Dovepress* | 3,545+ | 549 | 4,094 | |
| PubMed Central* | 465 | 175 | 640 | ||
| Totals | 4,010 | 724 | 4,734 | ||
| *Since 16 June 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar